Sheryl Coppola

A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose escalation results.

Anthony W. Tolcher, Benedito A. Carneiro, Afshin Dowlati et al. · Journal of Clinical Oncology · 2021 · 33 citations

Medicine, Oncology, Pharmacology +14

Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study

Hari V. Kalluri, Ryota Kikuchi, Sheryl Coppola et al. · Clinical and Translational Science · 2020 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Cristina Gasparetto, Kristian M. Bowles, Al‐Ola Abdallah et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A phase III, randomized, multicenter, open-label study of venetoclax or pomalidomide in combination with dexamethasone in patients with t(11;14)-positive relapsed/refractory multiple myeloma.

María‐Victoria Mateos, Philippe Moreau, Meletios Α. Dimopoulos et al. · Journal of Clinical Oncology · 2020 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +13

New options for diagnosis and control of gonorrheal urethritis in males using uncentrifuged first voided urine (FVU) as a specimen for culture.

Edward S. Murray, M J Benfari, Sheryl Coppola et al. · American Journal of Public Health · 1979 · 13 citations · Full text

Veterinary Medicine, Infectious Diseases, Urology +12